Business · 19/02/2021Updated: 10/17/2026 · 1 min read
FDA Requests Public Stakeholder Participation in Medical Device User Fee Reauthorization
Summary
The FDA is seeking public input from patient advocacy groups, healthcare professionals, and scientific experts to ensure continuity in the development of the next Medical Device User Fee Amendments (MDUFA) program, which is set to expire in September 2022.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →